Northeast Asia

The International Swaps and Derivatives Association has appointed Su Yen Chia as its new head of Asia Pacific public policy.

Index provider FTSE Russell is expanding the remit of its sustainability investment research in Asia Pacific to include hundreds more Chinese and Japanese securities.

Senior debt capital markets banker Pramod Shenoi joined independent research firm CreditSights at the end of last year.

Natixis has made two new hires for its Asia sponsor finance and mergers and acquisitions teams in Hong Kong.

Asian bond issuers went full speed ahead with their fundraising plans on Monday, launching new deals ahead of Chinese New Year holidays at the end of the month.

Hong Kong-listed MicroPort Scientific Corp is looking at spinning off and listing its heart treatment subsidiary, according to a stock exchange filing.

In this round-up, China’s central bank cut the required reserve ratio by 50bp on Monday, domestic financial institutions have been told to price loans based on the new benchmark and regulators have published draft rules on dealing with corporate bond defaults.

I-Mab, a China-based biopharmaceutical company, has kicked off the roadshow for its up to $111.1m Nasdaq IPO, more than two months after filing draft documents with the US regulator.

Struggling Spanish construction group Aldesa saw a Christmas bounce in its Caa1-rated bonds, following a December 25 takeover deal and capital injection from China Railway Construction Corporation.

Property manager Central China New Life is planning to list in Hong Kong in the first quarter, said a source familiar with the transaction.

Smoore International Holdings, a manufacturer of vaping technology, is lining up a Hong Kong IPO of more than $500m in the first quarter of 2020, according to a source familiar with the matter.

The Securities and Futures Commission has fined RHB Securities Hong Kong HK$6.4m ($821,516) for failing to comply with a number of regulatory requirements.